TRT and heart health sit at the center of one of the longest debates in men’s medicine. For many men, that single worry has decided whether they even consider testosterone therapy. However, the science has moved on. A large 2023 cardiovascular safety trial called TRAVERSE finally gave clinicians clear data. As a result, the conversation today centers on how to use TRT safely, not whether to use it at all. In this guide, we explain what the evidence shows and how to lower risk on therapy.
Why men worry about TRT and heart health
For years, two small studies tied TRT and heart health to possible harm. Because of those reports, the FDA added a label warning to testosterone products in 2015. However, the studies had design flaws, and later analyses challenged their conclusions. Still, the warning shaped how doctors and patients viewed therapy. Many men with classic symptoms delayed treatment because they feared a heart attack. Meanwhile, demand for therapy kept rising across clinics worldwide. Therefore, the field needed a properly powered trial to settle the question.
What the TRAVERSE trial says about TRT and heart health
The TRAVERSE trial transformed the conversation around TRT and heart health. Researchers randomized more than 5,000 men aged 45 to 80 with low testosterone. Each volunteer had existing or likely cardiovascular disease. Half received testosterone gel, and half received placebo. After about 22 months, the study found no meaningful difference in major cardiac events. In other words, the two groups had similar rates of heart attack, stroke, and cardiovascular death.
However, the trial did flag a few side effects worth knowing. Men on therapy showed slightly higher rates of pulmonary embolism, atrial fibrillation, and acute kidney injury. Therefore, TRT is not free of risk, but the major fear of cardiac death appears unfounded. Overall, the result gave clinicians the reassurance they had waited a decade to see.
Heart changes worth tracking on testosterone therapy
Testosterone shifts several markers that touch heart health. First, it can raise hematocrit, which thickens the blood and may increase clotting risk. As a result, your clinician should check a complete blood count every few months in the first year. Second, TRT can shift blood pressure in some men. Therefore, regular home readings help catch any rise early. Third, lipid panels can change, though the effect is usually small. In addition, the atrial fibrillation signal from TRAVERSE means men with prior arrhythmias should tell their cardiologist before starting. For more on these labs, see our guide on TRT and hematocrit.
How clinicians lower cardiovascular risk on TRT
Good TRT care is layered. First, a thorough baseline workup screens for hidden heart disease, clotting disorders, and uncontrolled blood pressure. Next, the clinician picks the lowest effective dose, because higher doses raise red blood cell counts faster. In addition, many clinics now prefer smaller, twice-weekly injections over a single large weekly dose. This pattern keeps levels stable. For details, read our breakdown of TRT injection frequency. Moreover, ongoing monitoring of blood pressure, hematocrit, and lipids catches problems early. Therefore, a structured follow-up program is one of the strongest tools for protecting your heart on therapy.
Lifestyle steps that protect your heart on therapy
Therapy works best alongside lifestyle work. First, regular aerobic exercise lowers resting blood pressure and improves vascular function. In addition, strength training improves insulin sensitivity, which also helps the heart. Meanwhile, a Mediterranean-style diet rich in vegetables, fish, and olive oil reduces inflammation. Sleep is the next lever, because poor sleep raises blood pressure and stress hormones. Therefore, aim for seven to eight hours every night. Moreover, limiting alcohol and stopping smoking remain the highest-impact moves any man on TRT can make. For practical steps, see our post on testosterone and high blood pressure.
When TRT may not be right for your heart
Some men should pause before starting. First, anyone with a recent heart attack, stroke, or unstable angina in the past six months should wait. The cardiologist should clear them first. In addition, men with untreated severe sleep apnea may worsen the condition on testosterone, which in turn strains the heart. Moreover, men with a history of deep-vein thrombosis or pulmonary embolism need careful counseling because of the TRAVERSE clotting signal. For a wider safety overview, read is TRT safe and our TRT 12-week timeline. Therefore, an honest pre-treatment review matters more than any single lab value.
The bottom line on TRT and heart health
The fear around TRT and heart health no longer matches the evidence. The TRAVERSE trial showed no rise in major cardiac events, while flagging side effects clinicians can manage. Therefore, the right question is no longer whether TRT is safe for the heart. Instead, ask whether your heart is well-prepared for TRT. At Boost Health Clinic, we run a full cardiovascular review before therapy and track key markers throughout treatment. To learn more, see how TRT works or our guide to testosterone cypionate.
References: TRAVERSE Study (NEJM, 2023); National Institute on Aging — Testosterone Therapy; PubMed — Testosterone Cardiovascular Outcomes Review.
Related: Cardiovascular health is also tied to micronutrients like B12 — learn about proper vitamin B12 dosage for men.